APA (7th ed.) Citation

Yu, S., Zhuang, W., Gao, S., Li, T., Yan, X., Ouyang, G., & Zhang, P. (2025). Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission. Cancer Medicine, 14(14), 1. https://doi.org/10.1002/cam4.71081

Chicago Style (17th ed.) Citation

Yu, Shuling, Wanchuan Zhuang, Shengfa Gao, Tongyu Li, Xiao Yan, Guifang Ouyang, and Ping Zhang. "Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission." Cancer Medicine 14, no. 14 (2025): 1. https://doi.org/10.1002/cam4.71081.

MLA (9th ed.) Citation

Yu, Shuling, et al. "Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission." Cancer Medicine, vol. 14, no. 14, 2025, p. 1, https://doi.org/10.1002/cam4.71081.